The Venture Codex Logo

The Venture Codex

i&i Biotech Fund

6 Rue Adolphe, Luxembourg, 1116

Overview

Venture capital firm investing in European life science innovations.

Founded

2021

Deals · 12mo

4

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

Austria
Germany
The Netherlands
United Kingdom
...

Sector focus

—

Investment portfolio

9rounds
NAMEDATESIZE
Ternary Therapeutics
Mar 2026Participated
$5 MSeed
Antiverse
Mar 2026Participated
$9 MSeries A
T-Curx
Dec 2025Participated
$20 MSeries A
Captain T Cell
Nov 2025Participated
$23 MOther Equity
Antiverse
Oct 2024Led
$5 MSeed
Captain T Cell
May 2024Participated
$9 MSeed
HeartBeat.bio
Nov 2023Led
$5 MSeries A
Enzyre
Nov 2022Participated
$12 MSeries A
Sampling Human
Apr 2022Led
$2 MOther Equity
Ternary Therapeutics
Mar 2026Participated
$5 MSeed
Antiverse
Mar 2026Participated
$9 MSeries A
T-Curx
Dec 2025Participated
$20 MSeries A
Captain T Cell
Nov 2025Participated
$23 MOther Equity
Antiverse
Oct 2024Led
$5 MSeed
Captain T Cell
May 2024Participated
$9 MSeed
HeartBeat.bio
Nov 2023Led
$5 MSeries A
Enzyre
Nov 2022Participated
$12 MSeries A
Sampling Human
Apr 2022Led
$2 MOther Equity
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

i&i Biotech Fund: 9 funding rounds are recorded in the selected participation categories.All available history.
i&i Biotech Fund: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed12
Series A13
Other Equity11

Monthly Deal Activity

i&i Biotech Fund: 9 deals are recorded across 55 months.All available history.
i&i Biotech Fund: 9 deals are recorded across 55 months. All available history
MonthDeals
Apr '221
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '251
Jan '260
Feb '260
Mar '262
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

i&i Biotech Fund: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

i&i Biotech Fund: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
AI & Machine Learning2
Data, Analytics & IT2
Space & Frontier Tech2

Deal Size Distribution

i&i Biotech Fund: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

i&i Biotech Fund: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M2
$10M-$25M3
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

i&i Biotech Fund: Europe has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

i&i Biotech Fund: Europe has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
Europe8
United States1
i&i Biotech Fund: 20 co-investors are shown, with Brandenburg Kapital sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

i&i Biotech Fund: 20 co-investors are shown, with Brandenburg Kapital sharing 2 recorded deals. All available history
Co-investorShared deals
Brandenburg Kapital2
Hil-Invent2
Kadmos Capital2
Tensor Ventures2
AngelHub1
aws Grunderfonds1
Bayern Kapital1
BioMedPartners1
Daphni1
Demcon Investment1
Development Bank of Wales1
DOMiNO Ventures1
Formic Ventures1
Germany1
Innospark Ventures1
Innovation Investment Capital1
Invest AG1
Longevity Tech Fund1
Novalis Biotech1
Oost NL1

Investment Strategy

i&i Biotech Fund: Led accounts for 33% and participating for 67% of round participation.All available history.
i&i Biotech Fund: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led333%
Participating667%
i&i Biotech Fund: Single-lead accounts for 33% and co-led for 67% of lead dynamics.All available history.
i&i Biotech Fund: Single-lead accounts for 33% and co-led for 67% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead133%
Co-led267%

Team

Barbora Šumová